FDA
-
-
-
-
-
-
-
Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine
-
-
-
-
-
-
-
Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents
-
-
-
-
-
-
-
Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada
-
-
-
-
-
-
-
Bavarian Nordic Enters a New Multi-Year Vaccine Contract with the Government of Canada
-
-
-
-
-
-
-
Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian M
-
-
-
-
-
-
-
Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
-
-
-
-
-
-
-
Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen
-
324,655 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

